LRRC39, or Leucine Rich Repeat Containing 39, is a protein encoded by the LRRC39 gene in humans. Proteins in this family are characterized by leucine-rich repeat (LRR) domains. These domains typically consist of 20-30 amino acids and are rich in leucine, forming a structural motif that participates in protein-protein interactions.The exact function of the LRRC39 protein is not fully characterized, but leucine-rich repeat containing proteins are known to be involved in a variety of cellular functions, including signal transduction, cell adhesion, DNA repair, recombination, and regulation of gene expression. They are often key players in the immune response and development.
LRR-containing proteins can act as receptors or adaptor molecules that mediate specific ligand-receptor interactions. These interactions can trigger signal transduction pathways that culminate in a cellular response, such as the modulation of the cell cycle, apoptosis, or immune responses. Due to the versatility of the LRR domain in mediating protein-protein interactions, LRRC39 may engage in diverse functional complexes, affecting various signaling pathways or structural assemblies.Given the prominence of LRR motifs in a range of proteins with known functions, LRRC39 might be implicated in one or several of these processes. However, without specific studies detailing its expression pattern, interacting partners, or effects of gene knockdowns or mutations, the precise biological role of LRRC39 remains to be elucidated. Research into LRRC39 and similar leucine-rich repeat proteins continues to expand our understanding of cellular function and the intricate networks of protein interactions that underpin cellular physiology and the response to environmental cues. Insights into such proteins may reveal new aspects of cell biology and potential implications for disease mechanisms, diagnostics.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D may inhibit LRRC39 expression by intercalating into DNA, blocking RNA synthesis and affecting transcription of LRRC39. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide might inhibit LRRC39 expression by blocking protein synthesis, thereby reducing the production of LRRC39 protein. | ||||||
Chromomycin A3 | 7059-24-7 | sc-200907 | 10 mg | $255.00 | ||
Actinomycin C could potentially inhibit LRRC39 expression similarly to Actinomycin D, by interfering with RNA synthesis. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $95.00 $322.00 $663.00 $1438.00 | 6 | |
Rifampicin may inhibit LRRC39 expression by targeting bacterial-like RNA polymerase, potentially affecting the transcription of LRRC39. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $163.00 $316.00 | 436 | |
Puromycin might inhibit LRRC39 expression by prematurely terminating protein synthesis, thereby reducing LRRC39 production. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin has been suggested to inhibit LRRC39 expression by inhibiting protein synthesis at the translational level, affecting LRRC39 production. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Doxorubicin may inhibit LRRC39 expression by intercalating into DNA and impacting transcription, reducing the synthesis of LRRC39. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Etoposide could potentially inhibit LRRC39 expression by affecting topoisomerase II activity, influencing DNA transcription and LRRC39 synthesis. | ||||||
Blasticidin S Hydrochloride | 3513-03-9 | sc-204655A sc-204655 | 25 mg 100 mg | $360.00 $475.00 | 20 | |
Blasticidin S may inhibit LRRC39 expression by interfering with protein synthesis, potentially reducing the production of LRRC39. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $65.00 $99.00 $140.00 | 85 | |
Mitomycin C might inhibit LRRC39 expression by crosslinking DNA, affecting transcription and potentially reducing LRRC39 synthesis. | ||||||